Teva Pharmaceutical Shares Fall 13% Following Lower-than-Expected Q4 Results

(RTTNews) - Teva Pharmaceutical Industries Ltd. (TEVA) has seen a decline of 13.92 percent in its stock value during Wednesday afternoon trading following the release of fourth-quarter earnings.

The company reported adjusted earnings of 71 cents per share and $4.23 billion in fourth-quarter sales, which led to a retreat in its stock price.

Currently, TEVA is trading at $18.51, down by $3.02 from its previous close of $21.53. The stock opened at $18.61, with the day's trading range between $18.50 and $19.74.

The 52-week range for TEVA spans from $11.62 to $22.80, and volume for the day has reached about 25.82 million shares, higher than the average volume of nearly 9.81 million shares.